ABSTRACT
There is a long-standing interest in the use of melatonin (compound 1, MLT, Figure 20.1) and its derivatives for the treatment of a number of pathological conditions, mainly sleep disturbances and depression. Neuroprotective properties have also been shown for MLT in different animal models and in clinical studies (Srinivasan et al., 2011; Robertson et al., 2013).
